NCT07216352View on ClinicalTrials.gov

Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging

NANot yet recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 25, 2025

Primary Completion Date

March 30, 2026

Study Completion Date

May 30, 2026

Conditions
Laxity; Skin
Interventions
OTHER

AGE Serum

AGE serum is a topical that contains a high concentration of 30% Proxylane and a synergistic blend of fruit-derived flavonoids (blueberry, pomegranate) and Cassia alata extract.

Trial Locations (1)

92121

West Dermatology Research Center, San Diego

All Listed Sponsors
collaborator

L'Oreal

INDUSTRY

lead

Goldman, Butterwick, Fitzpatrick and Groff

OTHER

NCT07216352 - Evaluate the Safety and Efficacy of a Topical Serum (AGE Serum) in Improving Visible Signs of Aging | Biotech Hunter | Biotech Hunter